RXPA 380 is a C-terminal specific angiotensin-converting enzyme ( ACE ) inhibitor with a K i of 3 nM. RXPA 380 inhibits C-domain mutants of human recombinant ACE with an IC 50 of 2.5 nM.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Angiotensin-converting Enzyme (ACE)
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。